Nextech Invest

Nextech Invest is a global venture capital firm focused on investing in emerging biotechnology companies developing transformative cancer medicines. It supports portfolio companies through scientific validation and value creation stages, with investments spanning from company inception to late-stage rounds. The firm has been an early backer of notable biotech successes such as Blueprint Medicines and Peloton Therapeutics. As an investor, it does not have its own clinical results or pipeline. Its portfolio includes multiple leading biotech firms across the US and Europe working on precision medicine for cancer and related fields. Recent investments include participation in Be Biopharma’s Series C round to advance B cell medicines for hemophilia B and hypophosphatasia. The team includes experienced scientists, clinicians, investors, and industry leaders with deep expertise in oncology drug development.